Functions of the nuclear envelope and lamina in development and disease.

Recent findings that some 24 inherited diseases and anomalies are caused by defects in proteins of the NE (nuclear envelope) and lamina have resulted in a fundamental reassessment of the functions of the NE and underlying lamina. Instead of just regarding the NE and lamina as a molecular filtering device, regulating the transfer of macromolecules between the cytoplasm and nucleus, we now envisage the NE/lamina functioning as a key cellular 'hub' in integrating critical functions that include chromatin organization, transcriptional regulation, mechanical integrity of the cell and signalling pathways, as well as acting as a key component in the organization and function of the cytoskeleton.

[1]  Richard T. Lee,et al.  Increased mechanosensitivity and nuclear stiffness in Hutchinson–Gilford progeria cells: effects of farnesyltransferase inhibitors , 2008, Aging cell.

[2]  L. Ferrucci,et al.  Hutchinson-Gilford progeria syndrome. , 2008, The New England journal of medicine.

[3]  F. Collins,et al.  Phenotype and course of Hutchinson-Gilford progeria syndrome. , 2008, The New England journal of medicine.

[4]  Ferhaan Ahmad,et al.  Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease. , 2008, Journal of molecular and cellular cardiology.

[5]  Juliet A. Ellis,et al.  Nesprin-1 and -2 are involved in the pathogenesis of Emery Dreifuss muscular dystrophy and are critical for nuclear envelope integrity. , 2007, Human molecular genetics.

[6]  Yiider Tseng,et al.  Nuclear lamin A/C deficiency induces defects in cell mechanics, polarization, and migration. , 2007, Biophysical journal.

[7]  M. Fornerod,et al.  The inner nuclear envelope as a transcription factor resting place , 2007, EMBO reports.

[8]  A. Giobbie-Hurder,et al.  Disease Progression in Hutchinson-Gilford Progeria Syndrome: Impact on Growth and Development , 2007, Pediatrics.

[9]  P. Hussey,et al.  A novel role for the nuclear membrane protein emerin in association of the centrosome to the outer nuclear membrane , 2007, The Journal of cell biology.

[10]  H. Worman,et al.  "Laminopathies": a wide spectrum of human diseases. , 2007, Experimental cell research.

[11]  Francis S. Collins,et al.  A lamin A protein isoform overexpressed in Hutchinson–Gilford progeria syndrome interferes with mitosis in progeria and normal cells , 2007, Proceedings of the National Academy of Sciences.

[12]  T. Shimi,et al.  Alterations in mitosis and cell cycle progression caused by a mutant lamin A known to accelerate human aging , 2007, Proceedings of the National Academy of Sciences.

[13]  S. Rais-Bahrami,et al.  Lmo7 is an emerin-binding protein that regulates the transcription of emerin and many other muscle-relevant genes. , 2006, Human molecular genetics.

[14]  C. Stewart,et al.  The laminopathies: the functional architecture of the nucleus and its contribution to disease. , 2006, Annual review of genomics and human genetics.

[15]  M. Bergo,et al.  A farnesyltransferase inhibitor improves disease phenotypes in mice with a Hutchinson-Gilford progeria syndrome mutation. , 2006, The Journal of clinical investigation.

[16]  Juliet A. Ellis,et al.  The inner nuclear membrane protein Emerin regulates β‐catenin activity by restricting its accumulation in the nucleus , 2006, The EMBO journal.

[17]  K. Wilson,et al.  Multiple roles for emerin: implications for Emery-Dreifuss muscular dystrophy. , 2006, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[18]  Susan C. Brown,et al.  Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. , 2006, Brain : a journal of neurology.

[19]  B. Shneiderman,et al.  Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. , 2006, Brain : a journal of neurology.

[20]  I. Nonaka,et al.  Emerin-lacking mice show minimal motor and cardiac dysfunctions with nuclear-associated vacuoles. , 2006, The American journal of pathology.

[21]  F. Collins,et al.  Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson–Gilford progeria syndrome , 2006 .

[22]  Richard L. Frock,et al.  Lamin A/C and emerin are critical for skeletal muscle satellite cell differentiation. , 2006, Genes & development.

[23]  E. Hoffman,et al.  Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. , 2006, Human molecular genetics.

[24]  L. Mestroni,et al.  Thymopoietin (lamina‐associated polypeptide 2) gene mutation associated with dilated cardiomyopathy , 2005, Human mutation.

[25]  Richard T. Lee,et al.  Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells , 2005, The Journal of cell biology.

[26]  J. Rottman,et al.  Expression of an LMNA-N195K variant of A-type lamins results in cardiac conduction defects and death in mice. , 2005, Human molecular genetics.

[27]  M. Gelb,et al.  Blocking protein farnesyltransferase improves nuclear blebbing in mouse fibroblasts with a targeted Hutchinson-Gilford progeria syndrome mutation. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[28]  M. Patti,et al.  Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome. , 2005, The Journal of pediatrics.

[29]  Atul J Butte,et al.  Genome‐scale expression profiling of Hutchinson–Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis , 2004, Aging cell.

[30]  Richard L. Frock,et al.  A-type lamins regulate retinoblastoma protein function by promoting subnuclear localization and preventing proteasomal degradation. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[31]  Yosef Gruenbaum,et al.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson–Gilford progeria syndrome , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[32]  J. Bridger,et al.  Aging of Hutchinson–Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis , 2004, Experimental Gerontology.

[33]  Richard T. Lee,et al.  Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction. , 2004, The Journal of clinical investigation.

[34]  D. Fatkin,et al.  Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice. , 2004, The Journal of clinical investigation.

[35]  B. Contreras,et al.  Rb and N-ras Function Together To Control Differentiation in the Mouse , 2003, Molecular and Cellular Biology.

[36]  Pierre Cau,et al.  Lamin A Truncation in Hutchinson-Gilford Progeria , 2003, Science.

[37]  L. Mounkes,et al.  A progeroid syndrome in mice is caused by defects in A-type lamins , 2003, Nature.

[38]  Laura Scott,et al.  Recurrent de novo point mutations in lamin A cause Hutchinson–Gilford progeria syndrome , 2003, Nature.

[39]  W. Trimble,et al.  Drosophila syntaxin 16 is a Q-SNARE implicated in Golgi dynamics , 2002, Journal of Cell Science.

[40]  M. Reitman,et al.  Characterization of adiposity and metabolism in Lmna-deficient mice. , 2002, Biochemical and Biophysical Research Communications - BBRC.

[41]  R. Goldman,et al.  Nuclear lamins: building blocks of nuclear architecture. , 2002, Genes & development.

[42]  H. Worman,et al.  Properties of lamin A mutants found in Emery-Dreifuss muscular dystrophy, cardiomyopathy and Dunnigan-type partial lipodystrophy. , 2001, Journal of cell science.

[43]  C. Stewart,et al.  Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy. , 2001, Journal of cell science.

[44]  B. Delahunt,et al.  Smooth muscle cell depletion and collagen types in progeric arteries. , 2001, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[45]  F. Baas,et al.  Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with atrioventricular conduction disturbances (LGMD1B). , 2000, Human molecular genetics.

[46]  L. Mestroni,et al.  Lamin A/C gene mutation associated with dilated cardiomyopathy with variable skeletal muscle involvement. , 2000, Circulation.

[47]  J. Seidman,et al.  Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. , 1999, The New England journal of medicine.

[48]  Brian Burke,et al.  Loss of a-Type Lamin Expression Compromises Nuclear Envelope Integrity Leading to Muscular Dystrophy , 1999, The Journal of cell biology.

[49]  F. Muntoni,et al.  Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy , 1999, Nature Genetics.

[50]  E. Maestrini,et al.  Identification of a novel X-linked gene responsible for Emery-Dreifuss muscular dystrophy , 1994, Nature Genetics.

[51]  K. Murakami,et al.  Complex formation between lamin A and the retinoblastoma gene product: identification of the domain on lamin A required for its interaction. , 1994, Oncogene.

[52]  Y. Hotta,et al.  cDNA cloning of a germ cell specific lamin B3 from mouse spermatocytes and analysis of its function by ectopic expression in somatic cells. , 1993, The EMBO journal.

[53]  K. Weber,et al.  Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. , 1989, Development.

[54]  C. Stewart,et al.  Teratocarcinoma stem cells and early mouse embryos contain only a single major lamin polypeptide closely resembling lamin B , 1987, Cell.

[55]  G. Martin,et al.  Genetic modulation of the senescent phenotype in Homo sapiens. , 1989, Genome.